What We’re Reading 12/15/08


Dec 15th, 2008 11:10 AM EST
By Chandler.Smith

New York Times: The Glaxo-Gates Malaria Vaccine (editorial)
Researchers have been trying for more than 70 years to develop a vaccine against malaria. Two studies conducted in East Africa suggest that they are finally closing in on their goal. This NY Times editorial praises the Bill and Melinda Gates Foundation for enabling this research to go forward when the drug manufacturer was unwilling, on its own, to take the financial risk to try to develop a vaccine.

New York Times: Amid a Hopeful Mood, U.N. Talks Set Countries on Path Toward a Global Climate Treaty
The United Nations climate talks concluded in Poland on Saturday. The final documents give nations credit for saving forests and opening up a long-planned fund to help poor countries adapt to climate change. “Perhaps contributing most to the hopeful mood,” the NY Times reports, “were signs from high-level United States officials that the incoming administration of President-elect Barack Obama would be ready to hit the ground running with a new United States climate policy.”

-Chandler Smith

TAGS: Policy News, What We're Reading

 

Leave a Comment

 

Name (required)

 

Mail (will not be published) (required)

 

Website

 

Email me when someone else comments on this post.

One Blog

Popular Posts This Month

About the Blog

The ONE Blog is a daily log of the anti-poverty movement. The site is operated by ONE staff, with frequent contributions from volunteers, members and partner organizations.

The ONE Blog updates readers daily with the latest in global development news and analysis and what ONE members and our partners are doing around the world to influence world leaders in the fight against global poverty.

The content of each post and each comment represents the views of that author and does not necessarily reflect the views of ONE or ONE Action. ONE does not support or oppose any candidate for elected office, and any post expressing support or opposition for a candidate is not endorsed by ONE.